[PDF] Top 20 Rev. Bras. Hematol. Hemoter. vol.34 número1
Has 10000 "Rev. Bras. Hematol. Hemoter. vol.34 número1" found on our website. Below are the top 20 most common "Rev. Bras. Hematol. Hemoter. vol.34 número1".
Rev. Bras. Hematol. Hemoter. vol.34 número1
... Dr. Hagop M. Kantarjian, professor and director of the Leukemia Department at the M. D. Anderson Hospital in Houston, warned about a possible shortage in the United States of America of two key drugs used in the ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.34 número1
... Geographic variations in the distribution of these diseases are well documented: nodal subtypes are more frequent in Europe and North America, while extranodal forms, including natural k[r] ... See full document
6
Rev. Bras. Hematol. Hemoter. vol.34 número1
... Clinical characteristics according to the severity of clinical presentation are presented in Table 1. Sixteen (25.4%), 34 (54%) and 13 (20.6%) patients were classified as mild, moderate and severe, respectively. ... See full document
5
Rev. Bras. Hematol. Hemoter. vol.34 número1
... The patient participated in the "ulcer healing group" of Hospital de Base in São José do Rio Preto, São Paulo State, Brazil and the leg ulcers were treated. At an initial evaluation the patient had ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.34 número1
... In conclusion, cancer patients with cachexia syndrome might be at risk for HPS because of the release of high levels of cytokines such as IL-6 or TNF- α. We suggest that clinicians shoul[r] ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.34 número1
... 15. Oredugba FA, Savage KO. Anthropometric finding in Nigerian children with sickle cell disease. Pediatr Dent. 2002;24(4):321-5. 16. Souza PH, Oliveira RS, Rocha JM, Gravina MA, Vitral RF. Alterações esqueléticas ... See full document
4
Rev. Bras. Hematol. Hemoter. vol.34 número1
... Treatment options for patients with naïve or recurrent FL are still controversial, ranging from a "watch and wait" policy to hematopoietic stem cell transplantation. More recently, the availability ... See full document
6
Rev. Bras. Hematol. Hemoter. vol.34 número1
... This review will provide a general overview of the main studies conducted to evaluate the infertility rate among female Hodgkin's lymphoma survivors and risk factors associated to treatm[r] ... See full document
6
Rev. Bras. Hematol. Hemoter. vol.34 número1
... 14. Alexander N, Balmaseda A, Coelho IC, Dimaano E, Hien TT, Hung NT, Jänisch T, Kroeger A, Lum LC, Martinez E, Siqueira JB, Thuy TT, Villalobos I, Villegas E, Wills B; On behalf of the European Union, World Health ... See full document
6
Rev. Bras. Hematol. Hemoter. vol.34 número1
... The comparison of the control group and DM2 patients on hemodialysis revealed differences between the numbers of MN, nuclear buds and the comet assay results (Figure 3): significantly hi[r] ... See full document
5
Rev. Bras. Hematol. Hemoter. vol.34 número1
... Because of the importance of knowing the genetic variability of the HLA system and that the probability of finding an HLA-matched donor depends on the number of people registered in REDO[r] ... See full document
6
Rev. Bras. Hematol. Hemoter. vol.34 número1
... 1. World Health Organization. WHO Global consultation on universal access to safe blood transfusion, 9-11 June 2007, Ottawa, Canada [Internet]. Geneva: WHO; 2007. [cited 2009 Jun 21]. Available from: ... See full document
4
Rev. Bras. Hematol. Hemoter. vol.34 número1
... This study aimed to analyze the rate of self-exclusion at the Regional Blood bank in Montes Claros and to correlate this to donor characteristics such as age, marital status, gender, eth[r] ... See full document
4
Rev. Bras. Hematol. Hemoter. vol.34 número1
... The blood samples used in this work were collected from children who participated in the university extension project "Occurrence of parasitic infections and anemia in school age children of the Ayrton Senna ... See full document
3
Rev. Bras. Hematol. Hemoter. vol.34 número1
... Historically, external quality control programs in immunohematology, also referred to as proficiency programs, evolved from the initial desire of laboratory scientists to refine the accuracy and precision of their ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.34 número1
... A strategy, usually known as confidential unit exclusion (CUE), was created so that donors could confidentially exclude their own blood after the donation process in cases in which donor[r] ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.34 número1
... High levels of methemoglobin (> 5%) are associated with chocolate-colored blood, cyanosis, headaches, tachycardia, dyspnea and tachypnea and in severe methemoglobinemia coma and death[r] ... See full document
1
Rev. Bras. Hematol. Hemoter. vol.34 número1
... 2012;34(1):3-8 3 Comments on 'Clinical course of 63 children with hereditary spherocytosis: a retrospective study' – with the particular question: 'Should HS be treated the same way[r] ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.34 número6
... 15. Belini E Jr, da Silva DG, Torres L de S, de Almeida EA, Cancado RD, Chiattone C, et al. Oxidative stress and antioxidant capacity in sickle cell anaemia patients receiving different treatments and medications for ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.34 número6
... Quality of life in sickle cell disease: assessments by the 36-item Short Form Health Survey Questionnaire and Beck Depression Inventory.. Maria Lucia Ivo 1.[r] ... See full document
1
temas relacionados